Steve E. Krognes
2019
In 2019, Steve E. Krognes earned a total compensation of $2.5M as Chief Financial Officer and Treasurer at Denali Therapeutics, a 37% decrease compared to previous year.
Compensation breakdown
Bonus | $188,023 |
---|---|
Option Awards | $1,558,941 |
Salary | $470,057 |
Stock Awards | $305,830 |
Other | $7,834 |
Total | $2,530,685 |
Krognes received $1.6M in option awards, accounting for 62% of the total pay in 2019.
Krognes also received $188K in bonus, $470.1K in salary, $305.8K in stock awards and $7.8K in other compensation.
Rankings
In 2019, Steve E. Krognes' compensation ranked 4,800th out of 13,971 executives tracked by ExecPay. In other words, Krognes earned more than 65.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,800 | 66th |
Manufacturing | 1,788 | 69th |
Chemicals And Allied Products | 621 | 72nd |
Drugs | 523 | 72nd |
Biological Products, Except Diagnostic Substances | 114 | 71st |
Krognes' colleagues
We found three more compensation records of executives who worked with Steve E. Krognes at Denali Therapeutics in 2019.
News
Denali Therapeutics CEO Ryan Watts' 2021 pay jumps 36% to $13M
April 19, 2022
Denali Therapeutics CEO Ryan Watts' 2020 pay jumps 87% to $9.3M
April 22, 2021
Denali Therapeutics CEO Ryan Watts' 2019 pay slips 17% to $5M
April 22, 2020
Denali Therapeutics CEO Ryan Watts' 2018 pay jumps 338% to $6M
April 18, 2019